Zusammenfassung
Fünfundsechzig unvorbehandelte Patienten (34 Frauen, 31 Männer) mit akuter myeloischer Leukämie wurden zur Remissionsinduktion mit einer Kombination aus Cytarabin (100 mg/m2/Tag kontinuierlich i.v. Tage 1–7) und Daunorubicin (45 mg/m2/Tag i.v. Tage 1–3) behandelt. Das Alter der Patienten lag zwischen 15 und 71 (Median 43) Jahren. Bei 36 Patienten ( = 55%) wurde eine Vollremission erreicht. Im Mittel wurden 1,5 Therapiezyklen und 41 Tage benötigt, um die Vollremission zu erreichen. Geschlecht und Leukämietyp schienen die Remissionsrate nicht zu beeinflussen. Das Alter ( > 50 Jahre) war ebenfalls ohne signifikanten Einfluß auf die Remissionsrate, prädisponierte jedoch zu letalen Komplikationen. Zur Remissionserhaltung wurde während des ersten Jahres alle 4 Wochen und während des zweiten Jahres alle 6 Wochen Cytarabin (200 mg/m2/Tag i.v. in 2 Dosen Tage 1–5) alternierend in Kombination mit einer der folgenden Substanzen: 6-Thioguanin (200 mg/m2/Tag p.o. in 2 Dosen Tage 1–5), Cyclophosphamid (800mg/m2 i.v. Tag 1), CCNU (100 mg p.o. Tag 1) oder Daunorubicin (45 mg/m2/Tag i.v. Tage 1–2) gegeben. Die mediane Remissionsdauer und Überlebensdauer betrugen 11 bzw. 18 Monate. Vierundvierzig Prozent der Patienten war nach einem Jahr, 28% nach zwei Jahren und 14% nach 5 Jahren noch in Vollremission.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Scott RB (1957) Leukemia. Lancet 1:1053
Tivey H (1955) The natural history of untreated acute leukemia. Ann NY Acad Sci 60:322
Bodey GP, Coltman CA, Freireich EJ et al. (1974) Chemotherapy of acute leukemia. A comparison of Cytarabine alone and in combination with Vincristine, Prednisolone and Cyclophosphamide. Arch Intern Med 133:260
South West Oncology Group (1974) Cytarabine for acute leukemia in adults. Effect of schedule on therapeutic response. Arch Intern Med 133:251
Wiernik PH, Schimpff SC, Schiffer CA et al. (1976) A randomised comparison of Dauno-rubicin alone with a combination of Daunorubicin, Cytosine Arabinoside, Thioguanine and Pyrimethamine for the treatment of acute nonlymphocytic leukemia. Cancer Treat Rep 60:41
Yates JW, Wallace HJ jr, Ellison RR et al. (1973) Cytosine Arabinoside (NSC-63878) and Daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia. Cancer Chemother Rep 57:485
Frei E, III, Freireich EJ (1965) Progress and perspectives in the chemotherapy of acute leukemia. Adv Chemother 2:269
Powles RL, Selby PJ, Palu G et al. (1979) The nature of remission in acute myeloblastic leukemia. Lancet 2:674
Gunz FW, Bach BI, Crossen PE et al. (1973) Relevance of cytogenetic status in acute leukemia in adults. J Natl Cancer Inst 50:55
Cutler SJ, Ederer F (1958) Maximum utilisation of the Life-table method in analysing survival. J Chron Dis 8:699
Cassileth PA, Katz ME (1977) Chemotherapy for adult acute nonlymphocytic leukemia with Daunorubicin and Cytosine Arabinoside. Cancer Treat Rep 61:1441
Preisler HD, Rustum Y, Henderson ES et al. (1979) Treatment of acute nonlymphocytic leukemia: Use of anthracycline-cytosine arabinoside induction therapy and comparison of 2 maintenance regimens. Blood 53:455
Rai KR, Holland JF, Glidewell OJ et al. (1981) Treatment of acute myelocytic leukemia: A study by Cancer and Leukemia Group B. Blood 58:1203
Lister TA, Rohatiner AZS (1982) The treatment of acute myelogenous leukemia in adults. Seminars in Hematology 19:172
Whitecar JP jr, Bodey GP, Freireich EJ et al. (1972) Cyclophosphamide (NSC-26271), Vincristine (NSC-67574), Cytosine Arabinoside (NSC-63878) and Prednison (NSC-10023) (COAP) combination chemotherapy for acute leukemia in adults. Cancer Chemother Rep 56:543
Bodey GP, Coltmann CA, Hewlett JS et al. (1976) Progression in the treatment of adults with acute leukemia: Review of regimens containing Cytarabine studied by the South West Oncology Group. Arch Intern Med 136:1383
Clarkson BD (1972) Acute myelocytic leukemia in adults. Cancer 30:1572
Gee TS, Yu K-P, Clarkson BD (1969) Treatment of adult acute leukemia with Arabinosyl-cytosine and Thioguanine. Cancer 23:1019
Bodey GP, Rodriguez V (1978) Approaches to the treatment of acute leukemia and lymphoma in adults. Seminars in Hematology 15:221
Wiernik PH, Glidewell OJ, Hoglard HC et al. (1979) A Cancer and Leukemia Group ? study: A comparative trial of Daunorubicin, Cytosine Arabinoside and Thioguanine and a combination of the three agents for the treatment of acute myelocytic leukemia. Med Pediat Oncol 6:261
The Finnish Leukemia Group (1979) The effect of Thioguanine on a combination of Daunorubicin, Cytosine Arabinoside and Prednisone in the treatment of acute leukemia in adults. Scand J Hematol 23:124
Gale RB, Kenneth AF, Cline MJ et al. (1981) Intensive chemotherapy for acute myelogenous leukemia. Ann Intern Med 94:753
Büchner TH, Hiddemann W, Urbanitz D et al. (1982) The Münster Study of Intensified Induction and Consolidation without Maintenance Chemotherapy for AML-Results in 93 Patients — Cellular Determinations of Response and Remission Duration. Blut 45:219
Rees JKH, Sandler RM, Challener J et al. (1977) Treatment of Acute myeloid leukemia with a triple cytotoxic regimen: DAT. Br J Cancer 36:770
Hossfeld DK, Faltemeier MT, Schmidt CG (1979) Behandlungsergebnisse bei der akuten nicht-lymphatischen Leukämie des Erwachsenen. Dt Med Wschr 104:1595
Embury SH, Ellias L, Heller PH et al. (1977) Remission maintenance chemotherapy in acute myelogenous leukemia. West J Med 126:267
Lewis JP, Pajak T, Linman JW et al. (1981) Maintenance management of acute nonlymphocytic leukemia. Cancer Clin Trials 4:115
Omura GA, Vogler WR, Lynn MJ (1977) A controlled clinical trial of chemotherapy vs BCG vs no further therapy in remission maintenance of acute myelogenous leukemia. Proc Am Assoc Cancer Res and ASCO 22:272
Peterson BA, Bloomfield CD (1981) Long term disease-free survival in acute nonlymphocytic leukemia. Blood 57:1144
Gale PP (1979) Advances in the treatment of acute myelogenous leukemia. N Engl J Med 300:1189
Vaughan WP, Karp JE, Burke PJ (1980) Long chemotherapy-free remission after single-cycle timed-sequential chemotherapy for acute myelocytic leukemia. Cancer 45:859
Mayer RJ, Weinstein HJ, Corail FS (1982) The role of intensive post induction chemotherapy in the management of patients with acute myelogenous leukemia. Cancer Treat Rep 66:1455
Schaefer UW, Nowrousian MR, Öhl S et al. (1978) Cryopreservation of bone marrow. In: Rainer H et al. (eds) Cell-separation and cryobiology. Schattauer, Stuttgart New York, pp 243–254
Schaefer UW, Nowrousian MR, Öhl S et al. (1980) Autologous bone marrow transplantation. The influence of prolonged cytotoxic chemotherapy. In: Thierfelder et al. (eds) Im-munobiology of bone marrow transplantation. Springer, Berlin Heidelberg New York, pp 275–283
Bodey GP, Freireich EJ, Kenneth B et al. (1981) Prolonged remission in adults with acute leukemia following late intensification chemotherapy and immunotherapy. Cancer 47:1937
Bell R, Rohatiner AZS, Slevin ML et al. (1982) Short-term treatment for acute myelogenous leukemia. Brit Med J 284:1221
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Nowrousian, M.R., Kubaschinski, G., Hossfeld, D.K., Schaefer, U.W. (1983). Behandlungsergebnisse der akuten myeloischen Leukämie beim Erwachsenen. In: Schmidt, C.G. (eds) Aktuelle Probleme der Hämatologie und internistischen Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68998-7_7
Download citation
DOI: https://doi.org/10.1007/978-3-642-68998-7_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-12241-8
Online ISBN: 978-3-642-68998-7
eBook Packages: Springer Book Archive